A legal battle over plastic coffee containers has been resolved by two of America’s biggest coffee brands.
Kraft Foods Inc., which manages the Maxwell House brand in Tarrytown, has settled a patent lawsuit filed in September by Procter & Gamble Co., which formerly sold Folgers Coffee.
Procter’s lawsuit alleged that new four-pound plastic containers for Maxwell House infringed on Procter & Gamble patents for Folgers. The companies did not disclose the financial terms or details of the settlement.
“Kraft Foods is pleased to settle this matter with P&G in such an efficient and pragmatic way,” Marc Firestone, Kraft’s executive vice president of corporate and legal affairs, said in a written statement. “We look forward to moving ahead on our Maxwell House brand.”
Procter sold the Folgers brand in November to J.M. Smucker Co.
Barr Pharmaceuticals Inc. confirmed today that its Pomona-based subsidiary, Barr Laboratories Inc., has challenged four patents held by Amgen Inc. for its Sensipar drug, used by dialysis patients to treat side-effects of the treatment.
Barr said it filed an Abbreviated New Drug Application with the Food and Drug Administration on March 10, the first date the agency could accept such an application for the kidney drug.
On Monday, Amgen, along with patent partners Brigham and Womenâ€™s Hospital Inc. and NPS Pharmaceuticals Inc., filed suit against Barr and Israeli drug-maker Teva Pharmaceutical Industries Ltd. for planning to sell generic Sensipar before the expiration of patent protection.
Sensipar recorded $377 million in U.S. sales during the 12 months ending May, Barr said.
Teva, the world’s largest generic-drug maker, is buying Montvale, N.J.-based Barr for $9 billion, the companies said jointly earlier this month.
Shares of Barr were down fractionally in noontime trading to $65.81 a share.